当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い

オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得

インデックス付き
  • 索引コペルニクス
  • Google スカラー
  • シェルパ・ロミオ
  • Jゲートを開く
  • Genamics JournalSeek
  • 中国国家知識基盤 (CNKI)
  • 電子ジャーナルライブラリ
  • レフシーク
  • ハムダード大学
  • エブスコ アリゾナ州
  • OCLC-WorldCat
  • SWBオンラインカタログ
  • 仮想生物学図書館 (vifabio)
  • パブロン
  • ジュネーブ医学教育研究財団
  • ユーロパブ
  • ICMJE
このページをシェアする

抽象的な

Biomarkers for possible diagnosis of the small intestine mucous membrane atrophy

Marakhouski Y

Background: Methods for assessing small intestine mucous membrane atrophy (SIMA) by biomarkers are described. In a number of publications has been shown the possibility citrulline concentration in the blood using as a biomarker of SIMA. Aim: To increase the accuracy for recognition SIMA by the citrulline concentration in blood as the biomarker of enterocytes mass and additionally use a biomarker of intestinal mucosa mucins mass. Material and Methods: This study consists of several parts. Stage1: Citrulline, threonine and other amino acids concentration was detected in the blood of healthy individuals (47 people) and in patients with proven atrophy (20 patients -pts, Marsh IIIA and more). Stage 2: Check the proposed method by masking (30 pts): the specialist evaluating SIMA by the results of citrulline and threonine did not have information about the absence /presence SIMA by histology. Only after the conclusion about the state of the mucous membrane by biomarkers, all pts were examined by endoscopic with a biopsy and histological (specialists did not have information about the absence /presence SIMA by biomarkers). Step 3: Evaluation of the proposed method based on ROC analysis. Stage 4: Checking the occurrence of false results. In a randomized group of patients (100 pts) with intestinal diseases, the state of the small intestinal mucosa was assessed using biomarkers, and with a positive result, atrophy and high-resolution endoscopy with biopsy and histology were clarified. Data analysis and comparison was carried out using statistical processing software Statistica-6, version 6.1, series 1203d and Winpepi. Different models were used to calculate the citrulline (CI) and threonine (TI) index using the model formulas. Results: Positive values of CI (more than 0,1) the presence of SIMA should be determined, at lower values of CI - no change in enterocytes’ mass can be stated; for positive values of TI (>0,1) - reducing of the mass of mucosal mucines can be determined, at lower values of TI - no change in mass of mucins can be proven. SIMA detected with specificity – 0,89 (95% CI 0,57–0,98) and sensitivity 0,82 (95% CI 0,52–0,95). ROC analysis shown: the area under the characteristic curve (AUC) for SIMA detected was 0,97 (95% CI = 0,87–0,99). The false-positive rate was 6.7% (95% CI = 3–28%). When CI value is more than 0,1 and TI value is more than 0,1, the state of small intestinal mucosa can be evaluated as “definitely SIMA”; when CI more than 0,1, combined with TI less than 0,1 Conclusion: The presented results prove the possibility of using the proposed method for assessing the state of the mucous membrane of the small intestine by biomarkers as the citrulline (CI) and threonine (TI) index.